Safety and effectiveness of thermal radiofrequency applied to the musculocutaneous nerve for patients with spasticity

Sergio Otero-Villaverde,Jacobo Formigo-Couceiro,Rosa Martin-Mourelle,Antonio Montoto-Marques
DOI: https://doi.org/10.3389/fneur.2024.1369947
IF: 3.4
2024-06-11
Frontiers in Neurology
Abstract:Objective: Evaluate safety and effectiveness of thermal radiofrequency in the musculocutaneous nerve in patients with focal elbow flexor spasticity. Design: Ambispective observational follow-up study. Patients with focal spasticity secondary to central nervous system injury with elbow flexor pattern who received thermal radiofrequency treatment in the musculocutaneous nerve between 2021 and 2023 were included. Subjects: 12 patients. Methods: Ultrasound-guided thermal radiofrequency was applied to the musculocutaneous nerve at 80°C for 90 s. Effectiveness was assessed prior to thermal radiofrequency and at 6 months using scales to measure pain (VAS), spasticity (MAS), disability (DAS), quality of life (SQol-6D), patient-perceived and physician-perceived satisfaction (PIG-C, PGA), and goal attainment (GAS). Elbow joint range of motion was evaluated via goniometry. Safety was evaluated by assessing side effects. Results: Patients had statistically significant improvements in spasticity ( p = 0.003), severe elbow flexion ( p = 0.02), pain ( p = 0.046), functioning ( p < 0.05), and spasticity-related quality of life ( p < 0.05 in three sections). Furthermore, treatment goals were attained. Patient- and physician-perceived clinical improvement was achieved. Regarding side effects, two patients had dysesthesia that was self-limiting, with maximum duration of 1 month. Conclusion: Thermal radiofrequency in the musculocutaneous nerve can be a safe, effective treatment for patients with severe spasticity with an elbow flexor pattern.
neurosciences,clinical neurology
What problem does this paper attempt to address?